Effect of T-705 treatment on western equine encephalitis in a mouse model

Antiviral Research

Volumn 82, Issue 3, 2009, Pages 169-171

  Julander, Justin G ^a   Smee, Donald F ^a   Morrey, John D ^a   Furuta, Yousuke ^b  

^a UTAH STATE UNIVERSITY   (United States)

^b TOYAMA CHEMICAL CO LTD   (Japan)

Author keywords

Antiviral; Encephalitis; Mouse; T 705; Treatment; Western equine encephalitis virus

Indexed keywords

ANTIVIRUS AGENT; PYRAZINE DERIVATIVE; T 705; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL MODEL; EXUDATE; LACRIMATION DISORDER; LIMB WEAKNESS; MOUSE; MUSCLE SPASM; NEUROLOGIC DISEASE; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; RNA VIRUS INFECTION; SURVIVAL; TREATMENT DURATION; TREATMENT OUTCOME; VERO CELL; VIRUS ENCEPHALITIS; WESTERN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS;

ADMINISTRATION, ORAL; AMIDES; ANIMALS; ANTIVIRAL AGENTS; BODY WEIGHT; CERCOPITHECUS AETHIOPS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, WESTERN EQUINE; MICE; MICE, INBRED C57BL; PYRAZINES; SERUM; SURVIVAL ANALYSIS; VERO CELLS;

ANIMALIA; EQUIDAE; MUS; RNA VIRUSES; WESTERN EQUINE ENCEPHALOMYELITIS VIRUS;

EID: 64749095802     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2009.02.201     Document Type: Article

References (16)

1. Aguilar M.J. Pathological changes in brain and other target organs of infant and weanling mice after infection with non-neuroadapted western equine encephalitis virus. Infect. Immun. 2 (1970) 533-542
2. Anderson B.A. Focal neurologic signs in western equine encephalitis. Can. Med. Assoc. J. 130 (1984) 1019-1021
3. Anon., 2007. Toyama starts U.S. trials of polymerase inhibitor. RxTrials Institute Drug Pipeline Alert, http://www.fdanews.com/newsletter/article?articleId=91489&issueId=9890.
4. Calisher C.H. Medically important arboviruses of the United States and Canada. Clin. Microbiol. Rev. 7 (1994) 89-116
5. Furuta Y., Takahashi K., Fukuda Y., Kuno M., Kamiyama T., Kozaki K., Nomura N., Egawa H., Minami S., Watanabe Y., Narita H., and Shiraki K. In vitro and in vivo activities of anti-influenza virus compound T-705. Antimicrob. Agents Chemother. 46 (2002) 977-981
6. Furuta Y., Takahashi K., Kuno-Maekawa M., Sangawa H., Uehara S., Kozaki K., Nomura N., Egawa H., and Shiraki K. Mechanism of action of T-705 against influenza virus. Antimicrob. Agents Chemother. 49 (2005) 981-986
7. Gowen B.B., Wong M.H., Jung K.H., Sanders A.B., Mendenhall M., Bailey K.W., Furuta Y., and Sidwell R.W. In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections. Antimicrob. Agents Chemother. 51 (2007) 3168-3176
8. Julander J.G., Shafer K., Smee D.F., Morrey J.D., and Furuta Y. Activity of T-705 in a hamster model of yellow fever virus infection in comparison with that of a chemically related compound T-1106. Antimicrob. Agents Chemother. 53 (2009) 202-209
9. Julander J.G., Siddharthan V., Blatt L.M., Schafer K., Sidwell R.W., and Morrey J.D. Effect of exogenous interferon and an interferon inducer on western equine encephalitis virus disease in a hamster model. Virology 360 (2007) 454-460
10. Liu C., Voth D.W., Rodina P., Shauf L.R., and Gonzalez G. A comparative study of the pathogenesis of western equine and eastern equine encephalomyelitis viral infections in mice by intracerebral and subcutaneous inoculations. J. Infect. Dis. 122 (1970) 53-63
11. Morrey J.D., Taro B.S., Siddharthan V., Wang H., Smee D.F., Christensen A.J., and Furuta Y. Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents. Antiviral Res. 80 (2008) 377-379
12. Sidwell R.W., Barnard D.L., Day C.W., Smee D.F., Bailey K.W., Wong M.H., Morrey J.D., and Furuta Y. Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice. Antimicrob. Agents Chemother. 51 (2007) 845-851
13. Sidwell R.W., and Smee D.F. Viruses of the Bunya- and Togaviridae families: potential as bioterrorism agents and means of control. Antiviral Res. 57 (2003) 101-111
14. Takahashi K., Furuta Y., Fukuda Y., Kuno M., Kamiyama T., Kozaki K., Nomura N., Egawa H., Minami S., and Shiraki K. In vitro and in vivo activities of T-705 and oseltamivir against influenza virus. Antiviral Chem. Chemother. 14 (2003) 235-241
15. Takehara M. Antiviral effects of double-stranded RNA from rice dwarf virus on infection of mice with western equine encephalitis virus. Microbiol. Immunol. 21 (1977) 309-315
16. Wong J.P., Nagata L.P., Christopher M.E., Salazar A.M., and Dale R.M. Prophylaxis of acute respiratory virus infections using nucleic acid-based drugs. Vaccine 23 (2005) 2266-2268